Brad Connett
 Brad Connett  (pharma lobbyist) | |
|---|---|
 | |
| Nationality | US |
| Alma mater | University of North Carolina |
| Interests | • pharmaceutical industry • pandemics • vaccines |
Brad Connett has worked for the pharmaceutical company Henry Schein, Inc, the largest U.S. distributor of flu vaccines, since 1997. He has been included in the Medical Distribution Hall of Fame for his success in peddling its products.
Career
Brad Connett earned his Bachelor of Administration in Economics and Psychology from the University of North Carolina at Chapel Hill.
Connett currently serves as President of the pharmaceutical company Henry Schein Inc's U.S. department. Henry Schein Inc is the largest U.S. distributor of flu vaccines,[1]and one of the leading providers of products and services to physician offices, urgent care clinics, retail clinics, freestanding emergency rooms, etc in the United States. One of Henry Schein Inc's focus areas is "humanitarian relief, disaster preparedness and response".[2], through through partnerships with non-governmental organizations, product donations [...] and public-private partnerships.[3].
He is a Member of the Company's Executive Management Committee. Connett is responsible for leading the medical group's strategic direction, management, and business performance, including sales, marketing, operations, business development, and technology solutions. Before assuming this role in May of 2018, Mr. Connett held a number of increasingly responsible positions at the Company.
Throughout his career, he has received numerous industry honors, including the John F. Sasen Leadership Award from the Health Industry Distributors Association, in recognition of his service to the industry, and induction into the Medical Distribution Hall of Fame by Repertoire Magazine.
Henry Schein inc.
Henry Schein has been recognized by the Ethisphere Institute as the World's Most Ethical Company six times as of 2017.[4]
Henry Schein Inc. got dismissed from a 2019 trial alleging Schein and other manufacturers mounted a “false advertising campaign” to expand the market for opioids and Henry Schein and other companies reaped financial rewards by failing “to monitor appropriately and restrict” the drugs’ distribution. Court papers filed by Henry Schein denied that the company “made deliberate efforts to evade restrictions on opioid distribution or acted without regard for life.”Cite error: Closing </ref> missing for <ref> tag
Event Participated in
| Event | Start | End | Location(s) | Description |
|---|---|---|---|---|
| Event 201 | 18 October 2019 | 18 October 2019 | New York US | A Johns Hopkins Center for Health Security/World Economic Forum/Bill & Melinda Gates Foundation sponsored large scale simulation of a global coronavirus pandemic predicting an apocalyptic outcome. Held October 2019. |
